AstraZeneca Pharma India has received a certificate confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the period October 1, 2025, to October 31, 2025. The certificate, issued by Integrated Registry Management Services, ensures adherence to dematerialization processes and security standards.
Compliance Certificate Received
AstraZeneca Pharma India has received a certificate from Integrated Registry Management Services Private Limited confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The certificate is dated November 6, 2025 and covers the period from October 1, 2025 to October 31, 2025.
Details of Compliance
The certificate confirms adherence to regulations related to the dematerialization of securities. This includes ensuring that dematerialized securities are listed on relevant stock exchanges, that certificates of security are properly handled, and that the depository is correctly recorded as the registered owner. Integrated Registry Management Services, the Registrar and Transfer Agent (RTA), issued the certificate, confirming compliance with the stated regulations for AstraZeneca Pharma India.
Source: BSE
